Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$249,372
in 1 filing, $249K under 10b5-1 plans

Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RENTON HOLLINGS −$249K Director sold 31% of stake

Reading 67 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-06 Marquet Magda Director Grant or award · Stock Option (right to buy) +10,600 10,600
2023-01-06 Marquet Magda Director Grant or award · Restricted Stock Unit +3,900 3,900
2023-01-06 LOUMEAU ERIC J COO, General Counsel Grant or award · Stock Option (right to buy) +60,530 60,530
2023-01-06 LOUMEAU ERIC J COO, General Counsel Grant or award · Restricted Stock Unit +22,180 22,180
2023-01-06 Lizzul Paul F. Chief Medical Officer Grant or award · Stock Option (right to buy) +67,070 67,070
2023-01-06 Lizzul Paul F. Chief Medical Officer Grant or award · Restricted Stock Unit +24,580 24,580
2023-01-06 Hamill Laura Director Grant or award · Stock Option (right to buy) +10,600 10,600
2023-01-06 Hamill Laura Director Grant or award · Restricted Stock Unit +3,900 3,900
2023-01-06 FENTON DENNIS M Director Grant or award · Stock Option (right to buy) +10,600 10,600
2023-01-06 FENTON DENNIS M Director Grant or award · Restricted Stock Unit +3,900 3,900
2023-01-06 Faga Daniel Interim CEO Grant or award · Stock Option (right to buy) +194,900 194,900
2023-01-06 Faga Daniel Interim CEO Grant or award · Restricted Stock Unit +71,400 71,400
2022-09-14 Lizzul Paul F. Chief Medical Officer Grant or award · Restricted Stock Unit +12,000 12,000
2022-09-14 LOUMEAU ERIC J COO, General Counsel Grant or award · Restricted Stock Unit +12,000 12,000
2022-09-14 MULROY DENNIS Chief Financial Officer Grant or award · Restricted Stock Unit +12,000 12,000
2022-08-08 LOUMEAU ERIC J COO, General Counsel Sale −523 $25.00 $13K 0
2022-06-23 MULROY DENNIS Chief Financial Officer Grant or award · Stock Option (right to buy) +10,000 10,000
2022-06-23 LOUMEAU ERIC J COO, General Counsel Grant or award · Stock Option (right to buy) +10,000 10,000
2022-06-23 Lizzul Paul F. Chief Medical Officer Grant or award · Stock Option (right to buy) +10,000 10,000
2022-06-08 LOUMEAU ERIC J COO, General Counsel Exercise or conversion +2,500 $14.02 $35K 3,023

Page 21 of 27 · 522 trades